Place of sulfonylureas in the management of type 2 diabetes mellitus in South Asia: A consensus statement

Since their introduction in clinical practice in the 1950's, Sulfonylureas (SUs) have remained the main-stay of pharmacotherapy in the management of type 2 diabetes. Despite their well-established benefits, their place in therapy is inappropriately being overshadowed by newer therapies. Many of...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalra, Sanjay, Aamir, A. H., Raza, Abbas, Das, A. K., Azad Khan, A. K., Shrestha, Dina, Qureshi, Md Faisal, Md Fariduddin, Pathan, Md Faruque, Jawad, Fatema, Bhattarai, Jyoti, Tandon, Nikhil, Somasundaram, Noel, Katulanda, Prasad, Sahay, Rakesh, Dhungel, Sanjib, Bajaj, Sarita, Chowdhury, Subhankar, Ghosh, Sujoy, Madhu, S. V., Ahmed, Tofail, Bulughapitiya, Uditha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4566336/
https://www.ncbi.nlm.nih.gov/pubmed/26425465
http://dx.doi.org/10.4103/2230-8210.163171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4566336/
https://www.ncbi.nlm.nih.gov/pubmed/26425465
http://dx.doi.org/10.4103/2230-8210.163171

Ejemplares similares